Drug General Information (ID: DDIJUC06NW)
  Drug Name Ergocalciferol Drug Info Magnesium sulfate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Vitamins Analgesics
  Structure

 Mechanism of Ergocalciferol-Magnesium sulfate Interaction (Severity Level: Moderate)
     Increased risk of hypermagnesemia Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ergocalciferol Magnesium sulfate
      Mechanism Hypermagnesemia Hypermagnesemia
      Key Mechanism Factor 1
Factor Name Hypermagnesemia
Factor Description Hypomagnesemia is a condition that occurs when you have too much magnesium in your body. Symptoms of hypomagnesemia include: nausea, vomiting, neurological damage, abnormally low blood pressure (hypotension), flushing, and headaches.
      Mechanism Description
  • Increased risk of hypermagnesemia by the combination of Ergocalciferol and Magnesium sulfate 

Recommended Action
      Management Patients on chronic renal dialysis treated with a vitamin D analog should avoid magnesium-containing products.

References
1 Product Information. Hectorol (doxercalciferol). Genzyme Corporation, Cambridge, MA.
2 Product Information. One-Alpha (alfacalcidol). Pharmel Inc, Montreal, IN.
3 Product Information. Rocaltrol (calcitriol). Roche Laboratories, Nutley, NJ.
4 Product Information. Zemplar (paricalcitol). Abbott Pharmaceutical, Abbott Park, IL.